Pathways to Cardiovascular Therapeutics
Pathways to Cardiovascular Therapeutics
批准号:
8986055
负责人:
Joshua M Hare
金额:
$3.0万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-07-01 至 2016-06-30
关键词:
American Heart AssociationAnniversaryAreaAwardBackBiologyBudgetsCardiacCardiac developmentCardiologyCardiovascular systemCell TherapyCellsCollaborationsCommunitiesDisabled PersonsDiseaseDisease ProgressionEnsureEpigenetic ProcessEquilibriumEventFamilyFosteringFunctional disorderFundingFutureGoalsGrantHeart DiseasesHeart failureHomeostasisIndividualInstitutesInvestmentsIsraelLearningLeftLifeLocationLouisianaMedical ResearchMedical centerMicroRNAsMinorityMolecularNational Heart, Lung, and Blood InstituteOralPathway interactionsRecruitment ActivityRequest for ProposalsResearchResearch PersonnelScheduleScienceScientistSecureSignal PathwaySiteStem Cell ResearchTherapeuticTimeTissue EngineeringTravelUncertaintyUnderrepresented MinorityUniversitiesUtahWorkabstractingcareercombatcostdesignexperiencefollow-upgene therapyheart metabolisminduced pluripotent stem celllecturesmedical specialtiesmeetingsmethionylmethioninenext generationnoveloutreachpostersprogramspublic health relevancesuccesssymposiumtherapeutic targettrend
中文摘要
英文摘要
DESCRIPTION (provided by applicant): This is a new application for the Annual Summer 2015 Symposium of the Basic Cardiovascular Sciences (BCVS) of the American Heart Association (AHA). This conference has had continuous support from the NHLBI for the last 10 years and this will be the 11th Anniversary meeting. Support from the NHLBI has helped foster a meeting that has become the "go to" conference dealing with molecular cardiovascular biology and disease. It represents its sponsor, the BCVS of the AHA, which is the world's leading organization of cardiovascular scientists. This conference started originally two decades ago as the Council held a Molecular Cardiology conference in 1991 and then had several meetings initially hailed as the Snowbird Conference as it was held during the summer at Snowbird, Utah. The meeting became an annual event in 2002 and since 2004 this conference has been recognized as a permanent, recurring scientific meeting of the AHA and which is when R13 funding also commenced. The conference in recent years has added translational topics as well as the "bread and butter" of this meeting, which is basic molecular cardiovascular research. The conference has always attracted the leading researchers in fields such as microRNA, cardiac gene and cell therapy, cardiac development and most recently, tissue engineering and iPS cells. The attendance of this conference has climbed every year and in 2014 we had an all-time high attendance of over 600. As in past years, the conference will be held in July and this year will return to New Orleans (the site of the 2011 and 2012 meetings) after two years in Las Vegas. The meeting will be held at the Hilton New Orleans Riverside, New Orleans, LA. The planned agenda represents an ambitious, fast-paced meeting with 14 sessions over 4 days (July 13-16, 2015) including the Keynote lecture by Dr. Eric Olson. Young cardiovascular scientists will be highlighted as well through invited talks in each session and Posters will be presented over the course of 3 days of the conference. Organizers of this meeting are Drs. Asa Gustafsson (UCSD), Anthony Rosenzweig (Beth Israel Deaconess Medical Center) and David J. Lefer (Louisiana State University). The proposal request constitutes approximately 7% of the total meeting budget and as we have done over the last several years, support from this application will be used toward Cardiovascular Outreach Awards (minority travel awards) and Young Investigator Travel Awards.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Full-scale GMP Production for a Pre-Clinical Systemic Delivered Mesenchymal Stem Cells Derived Extracellular Vesicles For Cardiovascular Disease
-
批准号:10721103
-
项目类别:
-
资助金额:$28.87万
-
财政年份:2023
-
负责人:Joshua M Hare
-
依托单位:
1/2 Allogeneic Human Mesenchymal Stem Cell (MSC) Injection in Patients with Hypoplastic Left Heart Syndrome: A Phase IIb Clinical Trial
-
批准号:10274833
-
项目类别:
-
资助金额:$117.83万
-
财政年份:2020
-
负责人:Joshua M Hare
-
依托单位:
1/2 Allogeneic Human Mesenchymal Stem Cell (MSC) Injection in Patients with Hypoplastic Left Heart Syndrome: A Phase IIb Clinical Trial
-
批准号:10295008
-
项目类别:
-
资助金额:$65.79万
-
财政年份:2020
-
负责人:Joshua M Hare
-
依托单位:
Production Assistance for Cellular Therapies (PACT)- Cell Processing Facilities Cell manufacturing and process development services for PCT0031-02: GMP Production of iPSC Line and Scale-up of Cardiac
-
批准号:10090766
-
项目类别:
-
资助金额:$101.72万
-
财政年份:2019
-
负责人:Joshua M Hare
-
依托单位:
A Phase 2b Clinical Trial to Study the Efficacy of Longeveron Mesenchymal Stem Cells (LMSCs) to Treat Aging Frailty
-
批准号:9922198
-
项目类别:
-
资助金额:$197.43万
-
财政年份:2018
-
负责人:Joshua M Hare
-
依托单位:
A Randomized, Blinded, Placebo-Controlled Clinical Trial to Evaluate Longeveron Mesenchymal Stem Cell (LMSC) Therapy for Treating The Metabolic Syndrome
-
批准号:9925908
-
项目类别:
-
资助金额:$46.55万
-
财政年份:2017
-
负责人:Joshua M Hare
-
依托单位:
A Randomized, Blinded, Placebo-Controlled Clinical Trial to Evaluate Longeveron Mesenchymal Stem Cell (LMSC) Therapy for Treating The Metabolic Syndrome
-
批准号:9348026
-
项目类别:
-
资助金额:$15.0万
-
财政年份:2017
-
负责人:Joshua M Hare
-
依托单位:
Nitric Oxide and sex differences in cardiac repair
-
批准号:9331951
-
项目类别:
-
资助金额:$40.61万
-
财政年份:2017
-
负责人:Joshua M Hare
-
依托单位:
Cell Based Therapy for Non-Ischemic Dilated Cardiomyopathy
-
批准号:8288406
-
项目类别:
-
资助金额:$71.55万
-
财政年份:2012
-
负责人:Joshua M Hare
-
依托单位:
Cell Based Therapy for Non-Ischemic Dilated Cardiomyopathy
-
批准号:8448599
-
项目类别:
-
资助金额:$65.07万
-
财政年份:2012
-
负责人:Joshua M Hare
-
依托单位:
Cell Based Therapy for Non-Ischemic Dilated Cardiomyopathy
-
批准号:8628873
-
项目类别:
-
资助金额:$66.46万
-
财政年份:2012
-
负责人:Joshua M Hare
-
依托单位:
Cardioprotective Effect of Growth Hormone Releasing Hormone
-
批准号:8065336
-
项目类别:
-
资助金额:$64.43万
-
财政年份:2011
-
负责人:Joshua M Hare
-
依托单位:
Cardioprotective Effect of Growth Hormone Releasing Hormone
-
批准号:8208055
-
项目类别:
-
资助金额:$62.55万
-
财政年份:2011
-
负责人:Joshua M Hare
-
依托单位:
Cardioprotective Effect of Growth Hormone Releasing Hormone
-
批准号:8411600
-
项目类别:
-
资助金额:$64.93万
-
财政年份:2011
-
负责人:Joshua M Hare
-
依托单位:
Stem Cells for Dilated Cardiomyopathy
-
批准号:8502552
-
项目类别:
-
资助金额:$62.02万
-
财政年份:2011
-
负责人:Joshua M Hare
-
依托单位:
Stem Cells for Dilated Cardiomyopathy
-
批准号:8880266
-
项目类别:
-
资助金额:$60.41万
-
财政年份:2011
-
负责人:Joshua M Hare
-
依托单位:
Stem Cells for Dilated Cardiomyopathy
-
批准号:8300026
-
项目类别:
-
资助金额:$65.13万
-
财政年份:2011
-
负责人:Joshua M Hare
-
依托单位:
Stem Cells for Dilated Cardiomyopathy
-
批准号:8205725
-
项目类别:
-
资助金额:$63.95万
-
财政年份:2011
-
负责人:Joshua M Hare
-
依托单位:
Cardioprotective Effect of Growth Hormone Releasing Hormone
-
批准号:8589378
-
项目类别:
-
资助金额:$64.84万
-
财政年份:2011
-
负责人:Joshua M Hare
-
依托单位:
Stem Cells for Dilated Cardiomyopathy
-
批准号:8680353
-
项目类别:
-
资助金额:$63.89万
-
财政年份:2011
-
负责人:Joshua M Hare
-
依托单位:
海外基金